HIF1A and melanoma: Melanogenesis and its highly active intermediates exhibit cytotoxic, genotoxic, and mutagenic properties that stimulate glycolysis and hypoxia-inducible factor 1-alpha (HIF-1) activation, promote immunosuppression of tumors, melanoma progression, and immunotherapy resistance [57].